
Dr. Jürgen Beck
CMO
• Managed clinical development of 6 drugs which have been brought to market (Pirfenidone, Remimazolam, Alfuzosine, Mmisulpride, Mizolastin, Pramipexole)
• Former CDO at PAION, VP Clin. and Med. Affairs at PROMETH-ERA and VP and Head of Clin Ops at InterMune
• MD and MBA